Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03967587
Other study ID # IMPROVE
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date November 19, 2020
Est. completion date March 6, 2021

Study information

Verified date January 2022
Source Neosense Technologies
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is a non-blinded trial with one single intervention in sick newborn infants. The Neosense umbilical catheter will be used instead of the routinely used umbilical catheter on infants where the treating physician has ordered use of an umbilical catheter. The catheter will be connected to the Neosense monitor/measuring unit. Blood samples for blood gas analysis are collected from the patients according to the clinical routine (every 4th to 6th hour). Oxygen tension data from the Neosense measuring system, from the time points when a blood gas sample was collected, will be recorded. This data will be compared to the oxygen tension value from the blood gas sample collected at the same time point. The blood gas samples will be analysed according to clinical and laboratory routine. The infants will remain in the study as long as the Neosense measuring system is used.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date March 6, 2021
Est. primary completion date March 6, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Sick newborn infants where the clinical routine indicates use of an umbilical catheter. At least one of the criteria below should be fulfilled: - The infant needs invasive measurement of blood pressure. - The infant needs repetitive sampling of blood. - The infant needs prolonged infusion(s) > 2 days. - The infant needs infusion of vessel irritating and potentially vessel harming solutions. - The infant is born extremely preterm (before 28+0 weeks gestational age). - A newborn infant with severe respiratory disorder, requiring oxygen treatment (more than 40% Fraction of inspired oxygen (FiO2)). - The infant is undergoing therapeutic hypothermia following asphyxia ("oxygen deficiency at birth"). - The infant has a severe infection/sepsis. - Signed informed consent form by both parents (or guardians), (if the infant has only one parent (or guardian) one informed consent is required). Exclusion criteria: - Gastroschisis - Omphalocele - Peritonitis - Necrotizing enterocolitis - Omphalitis

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Neosense Umbilical Catheter
The Neosense umbilical catheter is used instead of the routinely used umbilical catheter

Locations

Country Name City State
Sweden Karolinska University Hospital Huddinge
Sweden Uppsala University Children's Hospital Uppsala

Sponsors (1)

Lead Sponsor Collaborator
Neosense Technologies

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement performance of an intravascular oxygen sensor in the Neosense system. The oxygen tension measured by the Neosense system, compared to the oxygen tension measured by a blood gas analyser. Average of measurement comparisons done at every blood gas sample, i.e. every 4th - 6th hour during the study (up to 8 days)
Secondary Clinical complications with the Neosense catheter. The number of occasions when the Neosense catheter had to be removed and the underlying reason. This includes all anticipated device effects as well as placing the catheter in the wrong vessel, impossible to measure blood pressure, collect blood samples and/or administer fluids. During study, up to 8 days
Secondary Any deviations from normal procedures when inserting an umbilical catheter. Number of attempts to place the catheter for each patient. Any accessories needed to introduce or handle the Neosense catheter. During day 1
Secondary Number of monitor lockups or battery depletions Timepoint for monitor lockup or battery depletion, in case of occurrence. During study, in average 4-5 days
Secondary Usability and functionality of the Neosense monitor. Occurence of anticipated adverse device effects for the monitor. During study, in average 4-5 days
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05995613 - Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Completed NCT03683316 - Work of Breathing and Kangaroo Mother Care
Recruiting NCT04429906 - Diagnostic Study of Huami Smart Wearable Device
Completed NCT05784103 - Comparison of Tissue Oxygenation Measurement Using Multimodal Devices N/A
Recruiting NCT06283914 - Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry
Recruiting NCT03873298 - Inhaled NO in IPF and COPD During 6 Minute Walk Test Phase 2
Completed NCT03439202 - Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions. N/A
Recruiting NCT05022264 - Remote Investigation and Assessment of Vital Signs
Completed NCT02834845 - Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension Phase 4
Suspended NCT04252547 - Effect of Kangaroo Care on Test Weighing N/A
Completed NCT04346498 - Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable N/A
Completed NCT02127333 - Role of Oxygen for Vascular Dysfunction N/A
Not yet recruiting NCT05451875 - Comparison of Continuous Non-invasive All Vital Signs Monitoring Devices With Invasive Gold Standard for Children
Completed NCT05683210 - Comparison of The Effects of Initial Oral Feeding by Cup and Bottle-Feeding of Preterm Infants N/A
Completed NCT02017691 - Cerebral Oxygenation to Guide Supplemental Oxygen Phase 1/Phase 2
Completed NCT05709262 - Comparison of Different Walk and Performance Test in Detecting Silent Hypoxia
Completed NCT05192785 - The Effects Incentive Spirometry Use in Coronary Artery Bypass Surgery N/A